Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Correlation between pyrolysis behaviors of the components and the overall pyrolysates from pulping spent liquor.

Lyu G, Lou R, Zhao Y, Wu S.

Bioresour Technol. 2018 Jul;259:343-348. doi: 10.1016/j.biortech.2018.03.061. Epub 2018 Mar 20.

PMID:
29574314
2.

MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment.

Xu X, Yu S, Sun W, Qin X, Chen Y, Zhou L, Lou R, Dong S, Shen B, Wu J, Zang J, Cao H, Shi M, Zhang Q, Feng J.

J Cancer Res Clin Oncol. 2018 Mar;144(3):431-438. doi: 10.1007/s00432-017-2562-8. Epub 2017 Dec 29.

PMID:
29288364
3.

Deep Eutectic Solvents (DESs) for the Isolation of Willow Lignin (Salix matsudana cv. Zhuliu).

Li T, Lyu G, Liu Y, Lou R, Lucia LA, Yang G, Chen J, Saeed HAM.

Int J Mol Sci. 2017 Oct 28;18(11). pii: E2266. doi: 10.3390/ijms18112266.

4.

PPARγ agonist efatutazone and gefitinib synergistically inhibit the proliferation of EGFR-TKI-resistant lung adenocarcinoma cells via the PPARγ/PTEN/Akt pathway.

Ni J, Zhou LL, Ding L, Zhao X, Cao H, Fan F, Li H, Lou R, Du Y, Dong S, Liu S, Wang Z, Ma R, Wu J, Feng J.

Exp Cell Res. 2017 Dec 15;361(2):246-256. doi: 10.1016/j.yexcr.2017.10.024. Epub 2017 Oct 26.

PMID:
29080795
5.

Photonic crystal materials and their application in biomedicine.

Chen H, Lou R, Chen Y, Chen L, Lu J, Dong Q.

Drug Deliv. 2017 Nov;24(1):775-780. doi: 10.1080/10717544.2017.1321059.

PMID:
28475387
6.

Novel small molecule guanidine Sigma1 inhibitors for advanced prostate cancer.

Salvino JM, Srikanth YVV, Lou R, Oyer HM, Chen N, Kim FJ.

Bioorg Med Chem Lett. 2017 May 15;27(10):2216-2220. doi: 10.1016/j.bmcl.2017.03.030. Epub 2017 Mar 18.

7.

Scalable-manufactured randomized glass-polymer hybrid metamaterial for daytime radiative cooling.

Zhai Y, Ma Y, David SN, Zhao D, Lou R, Tan G, Yang R, Yin X.

Science. 2017 Mar 10;355(6329):1062-1066. doi: 10.1126/science.aai7899. Epub 2017 Feb 9.

PMID:
28183998
8.

Engineering the Structural and Electronic Phases of MoTe2 through W Substitution.

Rhodes D, Chenet DA, Janicek BE, Nyby C, Lin Y, Jin W, Edelberg D, Mannebach E, Finney N, Antony A, Schiros T, Klarr T, Mazzoni A, Chin M, Chiu YC, Zheng W, Zhang QR, Ernst F, Dadap JI, Tong X, Ma J, Lou R, Wang S, Qian T, Ding H, Osgood RM Jr, Paley DW, Lindenberg AM, Huang PY, Pasupathy AN, Dubey M, Hone J, Balicas L.

Nano Lett. 2017 Mar 8;17(3):1616-1622. doi: 10.1021/acs.nanolett.6b04814. Epub 2017 Feb 6.

PMID:
28145719
9.

Correction of Pterygium Colli in Turner Syndrome: A Clinical Report and Review of the Surgical Management.

Lou RB, Konofaos P, Wallace RD.

J Craniofac Surg. 2016 Nov;27(8):2081-2083. doi: 10.1097/SCS.0000000000003044. Review.

PMID:
28005757
10.

Alginate-based microcapsules with galactosylated chitosan internal for primary hepatocyte applications.

Lou R, Xie H, Zheng H, Ren Y, Gao M, Guo X, Song Y, Yu W, Liu X, Ma X.

Int J Biol Macromol. 2016 Dec;93(Pt A):1133-1140. doi: 10.1016/j.ijbiomac.2016.09.078. Epub 2016 Sep 22.

PMID:
27667543
11.

Fabrication of stable galactosylated alginate microcapsules via covalent coupling onto hydroxyl groups for hepatocytes applications.

Lou R, Yu W, Song Y, Ren Y, Zheng H, Guo X, Lin Y, Pan G, Wang X, Ma X.

Carbohydr Polym. 2017 Jan 2;155:456-465. doi: 10.1016/j.carbpol.2016.08.098. Epub 2016 Aug 31.

PMID:
27702535
12.

An improved pH-responsive carrier based on EDTA-Ca-alginate for oral delivery of Lactobacillus rhamnosus ATCC 53103.

Zheng H, Gao M, Ren Y, Lou R, Xie H, Yu W, Liu X, Ma X.

Carbohydr Polym. 2017 Jan 2;155:329-335. doi: 10.1016/j.carbpol.2016.08.096. Epub 2016 Aug 29.

PMID:
27702519
13.

A crucial role for spatial distribution in bacterial quorum sensing.

Gao M, Zheng H, Ren Y, Lou R, Wu F, Yu W, Liu X, Ma X.

Sci Rep. 2016 Oct 4;6:34695. doi: 10.1038/srep34695.

14.

Compensated Semimetal LaSb with Unsaturated Magnetoresistance.

Zeng LK, Lou R, Wu DS, Xu QN, Guo PJ, Kong LY, Zhong YG, Ma JZ, Fu BB, Richard P, Wang P, Liu GT, Lu L, Huang YB, Fang C, Sun SS, Wang Q, Wang L, Shi YG, Weng HM, Lei HC, Liu K, Wang SC, Qian T, Luo JL, Ding H.

Phys Rev Lett. 2016 Sep 16;117(12):127204. Epub 2016 Sep 16.

PMID:
27689296
15.

Microfabrication of a tunable collagen/alginate-chitosan hydrogel membrane for controlling cell-cell interactions.

Song Y, Zhang D, Lv Y, Guo X, Lou R, Wang S, Wang X, Yu W, Ma X.

Carbohydr Polym. 2016 Nov 20;153:652-662. doi: 10.1016/j.carbpol.2016.07.058. Epub 2016 Jul 18.

PMID:
27561537
16.

Controlling Gel Structure to Modulate Cell Adhesion and Spreading on the Surface of Microcapsules.

Zheng H, Gao M, Ren Y, Lou R, Xie H, Yu W, Liu X, Ma X.

ACS Appl Mater Interfaces. 2016 Aug 3;8(30):19333-42. doi: 10.1021/acsami.6b05778. Epub 2016 Jul 20.

PMID:
27404911
17.

A self-healing hydrogel formation strategy via exploiting endothermic interactions between polyelectrolytes.

Ren Y, Lou R, Liu X, Gao M, Zheng H, Yang T, Xie H, Yu W, Ma X.

Chem Commun (Camb). 2016 May 7;52(37):6273-6. doi: 10.1039/c6cc02472f. Epub 2016 Apr 14.

PMID:
27078585
18.

Effect of a quality improvement program on weaning from mechanical ventilation: a cluster randomized trial.

Zhu B, Li Z, Jiang L, Du B, Jiang Q, Wang M, Lou R, Xi X.

Intensive Care Med. 2015 Oct;41(10):1781-90. doi: 10.1007/s00134-015-3958-z. Epub 2015 Jul 9.

PMID:
26156108
19.

Weaning critically ill patients from mechanical ventilation: A prospective cohort study.

Pu L, Zhu B, Jiang L, Du B, Zhu X, Li A, Li G, He Z, Chen W, Ma P, Jia J, Xu Y, Zhou J, Qin L, Zhan Q, Li W, Jiang Q, Wang M, Lou R, Xi X.

J Crit Care. 2015 Aug;30(4):862.e7-13. doi: 10.1016/j.jcrc.2015.04.001. Epub 2015 Apr 16.

PMID:
25957496
20.

[Association between glucose variability and poor prognosis in critically ill patients].

Lou R, Jiang L.

Zhonghua Yi Xue Za Zhi. 2015 Feb 17;95(7):523-6. Chinese.

PMID:
25916929
21.

Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.

Zhao K, Lou R, Huang F, Peng Y, Jiang Z, Huang K, Wu X, Zhang Y, Fan Z, Zhou H, Liu C, Xiao Y, Sun J, Li Y, Xiang P, Liu Q.

Biol Blood Marrow Transplant. 2015 Jan;21(1):97-104. doi: 10.1016/j.bbmt.2014.09.030. Epub 2014 Oct 6.

22.

Unraveling molecular mechanistic differences in liver metabolism between lean and fat lines of Pekin duck (Anas platyrhynchos domestica): a proteomic study.

Zheng A, Chang W, Hou S, Zhang S, Cai H, Chen G, Lou R, Liu G.

J Proteomics. 2014 Feb 26;98:271-88. doi: 10.1016/j.jprot.2013.12.021. Epub 2014 Jan 9.

PMID:
24412807
23.

[Effects of performing pelvic lymph node dissection before versus after radical cystectomy].

Zhu ZS, Ye M, Shi HQ, Zhou YB, Chen LY, Liu QQ, Zhang CT, Lou RL, Xu LZ.

Zhonghua Yi Xue Za Zhi. 2013 Aug 27;93(32):2574-7. Chinese.

PMID:
24351600
24.

In vitro antibacterial activity of chinfloxacin, a new fluoroquinolone antibiotic.

Li GQ, Yuan M, Yang XY, Li CR, Hu XX, Zhang WX, Lou RH, Guo HY, You XW, Cen S, Jiang JD, You XF.

Chemotherapy. 2012;58(3):175-84. doi: 10.1159/000337084. Epub 2012 Jun 14.

PMID:
22699239
25.

In vivo antibacterial activity of chinfloxacin, a new fluoroquinolone antibiotic.

Li GQ, Bai XG, Li CR, Yang XY, Hu XX, Yuan M, Zhang WX, Lou RH, Guo HY, Jiang JD, You XF.

J Antimicrob Chemother. 2012 Apr;67(4):955-61. doi: 10.1093/jac/dkr557. Epub 2011 Dec 29.

PMID:
22210757
26.

In vivo antibacterial activity of nemonoxacin, a novel non-fluorinated quinolone.

Li CR, Li Y, Li GQ, Yang XY, Zhang WX, Lou RH, Liu JF, Yuan M, Huang P, Cen S, Yu LY, Zhao LX, Jiang JD, You XF.

J Antimicrob Chemother. 2010 Nov;65(11):2411-5. doi: 10.1093/jac/dkq341. Epub 2010 Sep 21.

PMID:
20858687
27.

[Prognostic significance of metastatic lymph node ratio in colorectal cancer].

Zhao Y, Li DC, Lou RC, Chen WP, Chen GP, Fan YT.

Zhonghua Zhong Liu Za Zhi. 2009 Oct;31(10):764-8. Chinese.

PMID:
20021830
28.

The use of skin substitutes in hand burns.

Lou RB, Hickerson WL.

Hand Clin. 2009 Nov;25(4):497-509. doi: 10.1016/j.hcl.2009.06.002. Review.

PMID:
19801123
29.

Connectivity for healthcare and well-being management: examples from six European projects.

Kamel Boulos MN, Lou RC, Anastasiou A, Nugent CD, Alexandersson J, Zimmermann G, Cortes U, Casas R.

Int J Environ Res Public Health. 2009 Jul;6(7):1947-71. doi: 10.3390/ijerph6071947. Epub 2009 Jul 6.

30.

In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.

You XF, Li CR, Yang XY, Yuan M, Zhang WX, Lou RH, Wang YM, Li GQ, Chen HZ, Song DQ, Sun CH, Cen S, Yu LY, Zhao LX, Jiang JD.

Antimicrob Agents Chemother. 2009 Oct;53(10):4525-8. doi: 10.1128/AAC.00223-09. Epub 2009 Jul 27.

31.

Syntheses of novel high affinity ligands for opioid receptors.

Wentland MP, Lou R, Lu Q, Bu Y, Denhardt C, Jin J, Ganorkar R, VanAlstine MA, Guo C, Cohen DJ, Bidlack JM.

Bioorg Med Chem Lett. 2009 Apr 15;19(8):2289-94. doi: 10.1016/j.bmcl.2009.02.078. Epub 2009 Feb 25.

32.

Syntheses and opioid receptor binding properties of carboxamido-substituted opioids.

Wentland MP, Lou R, Lu Q, Bu Y, VanAlstine MA, Cohen DJ, Bidlack JM.

Bioorg Med Chem Lett. 2009 Jan 1;19(1):203-8. doi: 10.1016/j.bmcl.2008.10.134. Epub 2008 Nov 7.

PMID:
19027293
33.

Surgical complications secondary to decompressive craniectomy in patients with a head injury: a series of 108 consecutive cases.

Yang XF, Wen L, Shen F, Li G, Lou R, Liu WG, Zhan RY.

Acta Neurochir (Wien). 2008 Dec;150(12):1241-7; discussion 1248. doi: 10.1007/s00701-008-0145-9. Epub 2008 Nov 13.

PMID:
19005615
34.

Design at the atomic level: generation of novel hybrid biaryloxazolidinones as promising new antibiotics.

Zhou J, Bhattacharjee A, Chen S, Chen Y, Duffy E, Farmer J, Goldberg J, Hanselmann R, Ippolito JA, Lou R, Orbin A, Oyelere A, Salvino J, Springer D, Tran J, Wang D, Wu Y, Johnson G.

Bioorg Med Chem Lett. 2008 Dec 1;18(23):6179-83. doi: 10.1016/j.bmcl.2008.10.014. Epub 2008 Oct 7.

PMID:
18951792
35.

Design at the atomic level: design of biaryloxazolidinones as potent orally active antibiotics.

Zhou J, Bhattacharjee A, Chen S, Chen Y, Duffy E, Farmer J, Goldberg J, Hanselmann R, Ippolito JA, Lou R, Orbin A, Oyelere A, Salvino J, Springer D, Tran J, Wang D, Wu Y, Johnson G.

Bioorg Med Chem Lett. 2008 Dec 1;18(23):6175-8. doi: 10.1016/j.bmcl.2008.10.011. Epub 2008 Oct 7.

PMID:
18947996
36.

In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.

Li CR, Yang XY, Lou RH, Zhang WX, Wang YM, Yuan M, Li Y, Chen HZ, Hong B, Sun CH, Zhao LX, Li ZR, Jiang JD, You XF.

Antimicrob Agents Chemother. 2008 Nov;52(11):3875-82. doi: 10.1128/AAC.01400-07. Epub 2008 Aug 18.

37.

In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from hospitals in Beijing, China.

Yang XY, Li CR, Lou RH, Wang YM, Zhang WX, Chen HZ, Huang QS, Han YX, Jiang JD, You XF.

J Med Microbiol. 2007 Jan;56(Pt 1):71-6.

PMID:
17172520
38.
39.

The association of renal tubular acidosis and cyanotic congenital heart disease.

Vida VL, Mack R, Barnoya J, Larrazabal LA, Lou R, Castañeda AR.

J Thorac Cardiovasc Surg. 2005 Nov;130(5):1466-7. No abstract available.

40.

Lipopolysaccharide upregulates renal shiga toxin receptors in a primate model of hemolytic uremic syndrome.

Clayton F, Pysher TJ, Lou R, Kohan DE, Denkers ND, Tesh VL, Taylor FB Jr, Siegler RL.

Am J Nephrol. 2005 Nov-Dec;25(6):536-40. Epub 2005 Sep 22.

PMID:
16179829
41.

[Preoperative chemoradiotherapy as neoadjuvant therapy for 35 patients with locally advanced lower rectal carcinoma].

Feng HY, Li DC, Lou RC, Zhu Y, Liu LY.

Zhonghua Wei Chang Wai Ke Za Zhi. 2005 Mar;8(2):125-8. Chinese.

PMID:
16155821
42.

Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 3: 8-Thiocarboxamido and 8-thioformamido derivatives of cyclazocine.

Wentland MP, Sun X, Bu Y, Lou R, Cohen DJ, Bidlack JM.

Bioorg Med Chem Lett. 2005 May 16;15(10):2547-51.

PMID:
15863314
43.

Synthesis and opioid receptor binding properties of a highly potent 4-hydroxy analogue of naltrexone.

Wentland MP, Lu Q, Lou R, Bu Y, Knapp BI, Bidlack JM.

Bioorg Med Chem Lett. 2005 Apr 15;15(8):2107-10.

PMID:
15808478
44.

[Effects of XW630 on the expression of type I collagen protein in the epiphyseal plates of mice].

Li L, Weng L, Zhang Y, Lou R, Zheng H.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2003 Jan;34(1):86-8. Chinese.

PMID:
15600190
45.

[Interactions between domains within the NH2- and COOH-terminal fragments of presenilins].

Mei P, Lou R, Li L, Zhou Y, Gong J, Chen Y, Wu G, Shen Y.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2000 Dec;22(6):536-9. Chinese.

PMID:
12903398
46.

[Fragile X mental retardation protein interacts with human NDK/Nm23-H2].

Lou R, Mei PC, Gong JY, Zhu N, Kou ZH, Wu GY, Shen Y.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2001 Dec;23(6):580-4. Chinese.

PMID:
12901102
47.

Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 2: 8-formamidocyclazocine analogues.

Wentland MP, Sun X, Ye Y, Lou R, Bidlack JM.

Bioorg Med Chem Lett. 2003 Jun 2;13(11):1911-4.

PMID:
12749896
48.

Syntheses and opioid receptor binding affinities of 8-amino-2,6-methano-3-benzazocines.

Wentland MP, Ye Y, Cioffi CL, Lou R, Zhou Q, Xu G, Duan W, Dehnhardt CM, Sun X, Cohen DJ, Bidlack JM.

J Med Chem. 2003 Feb 27;46(5):838-49.

PMID:
12593663
49.

C-mycprotein expression upregulated by 2-(3-estrone-N-ethyl piperazine-methyl) tetracycline in bone.

Weng LL, Li LZ, Zhang YL, Lou RL, Zheng H.

Yao Xue Xue Bao. 2002 Oct;37(10):771-4.

PMID:
12567859
50.

Gene expression profiling in developing human hippocampus.

Zhang Y, Mei P, Lou R, Zhang MQ, Wu G, Qiang B, Zhang Z, Shen Y.

J Neurosci Res. 2002 Oct 15;70(2):200-8.

PMID:
12271469

Supplemental Content

Support Center